Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) FCF Margin: 2020-2025

Historic FCF Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 29.04%.

  • Cellebrite DI's FCF Margin fell 1164.00% to 29.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.22%, marking a year-over-year increase of 567.00%. This contributed to the annual value of 30.81% for FY2024, which is 103.00% up from last year.
  • Cellebrite DI's FCF Margin amounted to 29.04% in Q3 2025, which was down 9.12% from 31.95% recorded in Q2 2025.
  • Cellebrite DI's 5-year FCF Margin high stood at 63.41% for Q4 2024, and its period low was -13.20% during Q1 2022.
  • Over the past 3 years, Cellebrite DI's median FCF Margin value was 29.04% (recorded in 2025), while the average stood at 31.28%.
  • Per our database at Business Quant, Cellebrite DI's FCF Margin slumped by 4,340bps in 2021 and then spiked by 3,445bps in 2023.
  • Cellebrite DI's FCF Margin (Quarterly) stood at 45.02% in 2021, then spiked by 515bps to 50.17% in 2022, then tumbled by 62bps to 49.55% in 2023, then skyrocketed by 1,386bps to 63.41% in 2024, then plummeted by 1,164bps to 29.04% in 2025.
  • Its FCF Margin was 29.04% in Q3 2025, compared to 31.95% in Q2 2025 and 21.59% in Q1 2025.